• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的附件区实性肿块超声造影风险分层模型:前瞻性多中心研究和风险调整。

A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment.

机构信息

Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Department of Ultrasound, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Eur Radiol. 2024 Sep;34(9):5978-5988. doi: 10.1007/s00330-024-10639-1. Epub 2024 Feb 19.

DOI:10.1007/s00330-024-10639-1
PMID:38374482
Abstract

OBJECTIVES

To evaluate the additional advantages of integrating contrast-enhanced ultrasound (CEUS) into the Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound (US) for the characterization of adnexal lesions with solid components.

MATERIALS AND METHODS

This prospective multicenter study recruited women suspected of having adnexal lesions with solid components between September 2021 and December 2022. All patients scheduled for surgery underwent preoperative CEUS and US examinations. The lesions were categorized according to the O-RADS US system, and quantitative CEUS indexes were recorded. Pathological results served as the reference standard. Univariable and multivariable analyses were performed to identify risk factors for malignancy in adnexal lesions with solid components. Receiver operating characteristic (ROC) curve analysis was employed to assess diagnostic performance.

RESULTS

A total of 180 lesions in 175 women were included in the study. Among these masses, 80 were malignant and 100 were benign. Multivariable analysis revealed that serum CA-125, the presence of acoustic shadowing, and peak intensity (PI) ratio (PI/PI) of solid components on CEUS were independently associated with adnexal malignancy. The modified CEUS risk stratification model demonstrated superior diagnostic value in assessing adnexal lesions with solid components compared to O-RADS US (AUC: 0.91 vs 0.78, p < 0.001) and exhibited comparable performance to the Assessment of Different NEoplasias in the adnexa (ADNEX) model (AUC 0.91 vs 0.86, p = 0.07).

CONCLUSION

Our findings underscore the potential value of CEUS as an adjunctive tool for enhancing the precision of diagnostic evaluations of O-RADS US.

CLINICAL RELEVANCE STATEMENT

The promising performance of the modified CEUS risk stratification model suggests its potential to mitigate unnecessary surgeries in the characterization of adnexal lesions with solid components.

KEY POINTS

• The additional value of CEUS to O-RADS US in distinguishing between benign and malignant adnexal lesions with solid components requires further evaluation. • The modified CEUS risk stratification model displayed superior diagnostic value and specificity in characterizing adnexal lesions with solid components when compared to O-RADS US. • The inclusion of CEUS demonstrated potential in reducing the need for unnecessary surgeries in the characterization of adnexal lesions with solid components.

摘要

目的

评估对比增强超声(CEUS)与卵巢附件报告和数据系统(O-RADS)超声(US)联合应用在具有实性成分的附件病变特征中的额外优势。

材料和方法

本前瞻性多中心研究于 2021 年 9 月至 2022 年 12 月间招募了疑似具有实性成分附件病变的女性患者。所有计划手术的患者均接受术前 CEUS 和 US 检查。根据 O-RADS US 系统对病变进行分类,并记录定量 CEUS 指标。以病理结果为参考标准。采用单变量和多变量分析来确定具有实性成分的附件病变恶性的危险因素。采用受试者工作特征(ROC)曲线分析评估诊断性能。

结果

共纳入 175 例患者的 180 个病灶,其中 80 个为恶性,100 个为良性。多变量分析显示,血清 CA-125、声影的存在和 CEUS 实性成分的峰值强度(PI)比值(PI/PI)与附件恶性肿瘤独立相关。改良 CEUS 风险分层模型在评估具有实性成分的附件病变方面显示出优于 O-RADS US 的诊断价值(AUC:0.91 与 0.78,p<0.001),与附件不同肿瘤评估(ADNEX)模型相当(AUC 0.91 与 0.86,p=0.07)。

结论

本研究结果强调了 CEUS 作为增强 O-RADS US 诊断评估准确性的辅助工具的潜在价值。

临床相关性声明

改良 CEUS 风险分层模型的良好表现提示其在具有实性成分的附件病变特征评估中具有减少不必要手术的潜力。

要点

·CEUS 对 O-RADS US 在鉴别具有实性成分的良性和恶性附件病变中的附加价值需要进一步评估。

·与 O-RADS US 相比,改良 CEUS 风险分层模型在具有实性成分的附件病变特征评估中具有更高的诊断价值和特异性。

·CEUS 的纳入有可能减少具有实性成分的附件病变特征评估中不必要的手术。

相似文献

1
A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment.改良的附件区实性肿块超声造影风险分层模型:前瞻性多中心研究和风险调整。
Eur Radiol. 2024 Sep;34(9):5978-5988. doi: 10.1007/s00330-024-10639-1. Epub 2024 Feb 19.
2
Integrating Contrast-enhanced US to O-RADS US for Classification of Adnexal Lesions with Solid Components: Time-intensity Curve Analysis versus Visual Assessment.对比增强超声与 O-RADS 超声联合用于附件实性成分病变分类:时间-强度曲线分析与目测评估的比较。
Radiol Imaging Cancer. 2024 Nov;6(6):e240024. doi: 10.1148/rycan.240024.
3
Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.基于超声的风险模型在区分美国队列中良性和恶性卵巢肿瘤的诊断性能。
JAMA Netw Open. 2023 Jul 3;6(7):e2323289. doi: 10.1001/jamanetworkopen.2023.23289.
4
O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.O-RADS 联合增强超声在附件肿块风险分层中的应用。
J Ovarian Res. 2023 Aug 3;16(1):153. doi: 10.1186/s13048-023-01243-w.
5
Differentiating Benign From Malignant Ovarian Masses With Solid Components: Diagnostic Performance of CEUS Combined With IOTA Simple Rules and O-RADS.超声造影联合 IOTA 简单规则和 O-RADS 对卵巢实性成分良恶性肿块的鉴别诊断价值
Ultrasound Med Biol. 2024 Sep;50(9):1449-1458. doi: 10.1016/j.ultrasmedbio.2024.05.024. Epub 2024 Jun 13.
6
External Validation of O-RADS US Risk Stratification and Management System.O-RADS US 风险分层和管理系统的外部验证。
Radiology. 2022 Jul;304(1):114-120. doi: 10.1148/radiol.211868. Epub 2022 Apr 19.
7
Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.IOTA简易规则、简易规则风险评估、ADNEX模型和O-RADS在北美女性附件区良恶性病变鉴别中的表现
Ultrasound Obstet Gynecol. 2022 May;59(5):668-676. doi: 10.1002/uog.24777. Epub 2022 Apr 8.
8
Diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification for adnexal masses: a systematic review and meta-analysis.超声造影(CEUS)联合卵巢附件报告和数据系统(O-RADS)超声风险分层对附件包块的诊断性能:一项系统评价和荟萃分析
Clin Radiol. 2024 Sep;79(9):e1167-e1175. doi: 10.1016/j.crad.2024.05.021. Epub 2024 Jun 7.
9
Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.O-RADS 超声和 O-RADS MRI 用于卵巢和附件病变风险评估的系统评价和荟萃分析。
AJR Am J Roentgenol. 2023 Jul;221(1):21-33. doi: 10.2214/AJR.22.28396. Epub 2023 Feb 1.
10
Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.美国放射学院卵巢-附件报告和数据系统超声(O-RADS US)的验证:对 1054 个附件肿块的分析。
Gynecol Oncol. 2021 Jul;162(1):107-112. doi: 10.1016/j.ygyno.2021.04.031. Epub 2021 May 7.

引用本文的文献

1
Contrast-enhanced ultrasound findings of ovarian Sertoli-Leydig cell tumor: a case report with ultrasonographic-pathological insights.卵巢支持-间质细胞瘤的超声造影表现:一例具有超声-病理见解的病例报告
BMC Womens Health. 2025 Jul 18;25(1):358. doi: 10.1186/s12905-025-03910-0.
2
Diagnostic value of contrast-enhanced ultrasound in endometrial lesions.超声造影在子宫内膜病变中的诊断价值
BMC Womens Health. 2025 Jul 9;25(1):338. doi: 10.1186/s12905-025-03860-7.
3
Findings on conventional ultrasonography and contrast-enhanced ultrasonography in different histopathological subtypes of ovarian thecoma-fibroma group.

本文引用的文献

1
Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy.超声造影增强有助于提高 O-RADS-US 风险分层系统对恶性肿瘤的诊断性能。
Radiology. 2023 Aug;308(2):e223003. doi: 10.1148/radiol.223003.
2
Value of Contrast-Enhanced Ultrasound Parameters in the Evaluation of Adnexal Masses with Ovarian-Adnexal Reporting and Data System Ultrasound.超声造影参数在采用卵巢附件报告和数据系统超声评估附件包块中的价值
Ultrasound Med Biol. 2023 Jul;49(7):1527-1534. doi: 10.1016/j.ultrasmedbio.2023.02.015. Epub 2023 Apr 7.
3
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
卵巢纤维瘤-卵泡膜细胞瘤组不同组织病理学亚型的传统超声和超声造影检查结果
BMC Med Imaging. 2025 May 20;25(1):175. doi: 10.1186/s12880-025-01693-2.
4
Diagnostic value of contrast-enhanced ultrasound for the depth of myometrial infiltration in early endometrial cancer: a meta-analysis.超声造影对早期子宫内膜癌肌层浸润深度的诊断价值:一项Meta分析
Front Oncol. 2025 Mar 7;15:1493246. doi: 10.3389/fonc.2025.1493246. eCollection 2025.
5
Exploratory study on the enhancement of O-RADS application effectiveness for novice ultrasonographers via deep learning.通过深度学习提高新手超声检查医师O-RADS应用效果的探索性研究
Arch Gynecol Obstet. 2024 Dec;310(6):3111-3120. doi: 10.1007/s00404-024-07837-z. Epub 2024 Nov 23.
卵巢-附件报告和数据系统 (O-RADS) 词汇表以及国际卵巢肿瘤分析两步策略的外部验证,以将卵巢肿瘤分层为 O-RADS 风险组。
JAMA Oncol. 2023 Feb 1;9(2):225-233. doi: 10.1001/jamaoncol.2022.5969.
4
Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?联合使用O-RADS超声检查和CA-125能否提高评估不同绝经状态女性附件恶性肿瘤风险的诊断准确性?
J Ultrasound Med. 2023 Feb;42(3):675-685. doi: 10.1002/jum.16065. Epub 2022 Jul 26.
5
Ovarian Adnexal Reporting Data System (O-RADS) for Classifying Adnexal Masses: A Systematic Review and Meta-Analysis.用于附件包块分类的卵巢附件报告数据系统(O-RADS):一项系统评价和Meta分析
Cancers (Basel). 2022 Jun 27;14(13):3151. doi: 10.3390/cancers14133151.
6
External Validation of O-RADS US Risk Stratification and Management System.O-RADS US 风险分层和管理系统的外部验证。
Radiology. 2022 Jul;304(1):114-120. doi: 10.1148/radiol.211868. Epub 2022 Apr 19.
7
Comparison of conventional, doppler and contrast-enhanced ultrasonography in differential diagnosis of ovarian masses: a systematic review and meta-analysis.传统超声、多普勒超声和超声造影在卵巢肿块鉴别诊断中的比较:系统评价和荟萃分析。
BMJ Open. 2021 Dec 24;11(12):e052830. doi: 10.1136/bmjopen-2021-052830.
8
Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.IOTA简易规则、简易规则风险评估、ADNEX模型和O-RADS在北美女性附件区良恶性病变鉴别中的表现
Ultrasound Obstet Gynecol. 2022 May;59(5):668-676. doi: 10.1002/uog.24777. Epub 2022 Apr 8.
9
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.欧洲妇科肿瘤学会(ESGO)/国际妇产科超声学会(ISUOG)/国际妇产科联盟肿瘤学组(IOTA)/欧洲妇科内镜学会(ESGE)关于卵巢肿瘤术前诊断的共识声明。
Int J Gynecol Cancer. 2021 Jul;31(7):961-982. doi: 10.1136/ijgc-2021-002565. Epub 2021 Jun 10.
10
Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.美国放射学院卵巢-附件报告和数据系统超声(O-RADS US)的验证:对 1054 个附件肿块的分析。
Gynecol Oncol. 2021 Jul;162(1):107-112. doi: 10.1016/j.ygyno.2021.04.031. Epub 2021 May 7.